Time to rethink shoe-horning cell and gene therapies
Development and commercialization of cell and gene therapy requires embracing a shift in the traditional biopharmaceutical business model.
Part 1: How cell and gene therapy is transforming healthcare
First in a two-part series on overcoming challenges in cell and gene therapy.
Part 2: How cell and gene therapy is transforming healthcare
Second in a two-part series on overcoming challenges in cell and gene therapy.